156 related articles for article (PubMed ID: 24779391)
1. MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.
Yu L; Huang J; Zhai D; Liu L; Guo K; Long X; Xiong J; Zhang Z; Wang Y; Zhao Y; Wu P; Wang D; Lin Z; Wu J; Xiong N; Wang T
BMC Neurosci; 2014 Apr; 15():54. PubMed ID: 24779391
[TBL] [Abstract][Full Text] [Related]
2. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.
Kwok JB; Hallupp M; Loy CT; Chan DK; Woo J; Mellick GD; Buchanan DD; Silburn PA; Halliday GM; Schofield PR
Ann Neurol; 2005 Dec; 58(6):829-39. PubMed ID: 16315267
[TBL] [Abstract][Full Text] [Related]
3. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
[TBL] [Abstract][Full Text] [Related]
4. GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.
Kalinderi K; Fidani L; Katsarou Z; Clarimón J; Bostantjopoulou S; Kotsis A
Neurobiol Aging; 2011 Mar; 32(3):546.e1-5. PubMed ID: 19573950
[TBL] [Abstract][Full Text] [Related]
5. Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese.
Zhang N; Yu JT; Yang Y; Yang J; Zhang W; Tan L
Brain Res; 2011 May; 1391():147-53. PubMed ID: 21443865
[TBL] [Abstract][Full Text] [Related]
6. GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals.
Dobson-Stone C; Polly P; Korgaonkar MS; Williams LM; Gordon E; Schofield PR; Mather K; Armstrong NJ; Wen W; Sachdev PS; Kwok JB
PLoS One; 2013; 8(8):e71750. PubMed ID: 23951236
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.
Kwok JB; Loy CT; Hamilton G; Lau E; Hallupp M; Williams J; Owen MJ; Broe GA; Tang N; Lam L; Powell JF; Lovestone S; Schofield PR
Ann Neurol; 2008 Oct; 64(4):446-54. PubMed ID: 18991351
[TBL] [Abstract][Full Text] [Related]
8. Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.
Refenes N; Bolbrinker J; Tagaris G; Orlacchio A; Drakoulis N; Kreutz R
BMC Neurol; 2009 Jun; 9():26. PubMed ID: 19558713
[TBL] [Abstract][Full Text] [Related]
9. MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset.
Okunoye O; Ojo OO; Abiodun O; Abubakar S; Achoru C; Adeniji O; Agabi O; Agulanna U; Akinyemi R; Ali M; Ani-Osheku I; Arigbodi O; Bello A; Erameh C; Farombi T; Fawale M; Imarhiagbe F; Iwuozo E; Komolafe M; Nwani P; Nwazor E; Nyandaiti Y; Obiabo Y; Odeniyi O; Odiase F; Ojini F; Onwuegbuzie G; Osaigbovo G; Osemwegie N; Oshinaike O; Otubogun F; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Hernandez D; Bandres-Ciga S; Blauwendraat C; Singleton A; Houlden H; Hardy J; Rizig M; Okubadejo N
Parkinsonism Relat Disord; 2023 Aug; 113():105517. PubMed ID: 37467655
[TBL] [Abstract][Full Text] [Related]
10. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
[TBL] [Abstract][Full Text] [Related]
11. H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.
Miranda-Morales EG; Sandoval-Carrillo A; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Quiñones-Canales G; Ruano-Calderón LA; Arias-Carrión O; Salas-Pacheco JM
Neurosci Lett; 2019 Jan; 690():210-213. PubMed ID: 30339920
[TBL] [Abstract][Full Text] [Related]
12. Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: a study from India.
Das G; Misra AK; Das SK; Ray K; Ray J
Neurobiol Aging; 2012 Jul; 33(7):1485.e9-15. PubMed ID: 21130530
[TBL] [Abstract][Full Text] [Related]
13. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.
Goris A; Williams-Gray CH; Clark GR; Foltynie T; Lewis SJ; Brown J; Ban M; Spillantini MG; Compston A; Burn DJ; Chinnery PF; Barker RA; Sawcer SJ
Ann Neurol; 2007 Aug; 62(2):145-53. PubMed ID: 17683088
[TBL] [Abstract][Full Text] [Related]
14. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.
Das G; Misra AK; Das SK; Ray K; Ray J
Neurosci Lett; 2009 Aug; 460(1):16-20. PubMed ID: 19450659
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
[TBL] [Abstract][Full Text] [Related]
16. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
Tobin JE; Latourelle JC; Lew MF; Klein C; Suchowersky O; Shill HA; Golbe LI; Mark MH; Growdon JH; Wooten GF; Racette BA; Perlmutter JS; Watts R; Guttman M; Baker KB; Goldwurm S; Pezzoli G; Singer C; Saint-Hilaire MH; Hendricks AE; Williamson S; Nagle MW; Wilk JB; Massood T; Laramie JM; DeStefano AL; Litvan I; Nicholson G; Corbett A; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Sherman S; Al-hinti J; Drasby E; Nance M; Moller AT; Ostergaard K; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
Neurology; 2008 Jul; 71(1):28-34. PubMed ID: 18509094
[TBL] [Abstract][Full Text] [Related]
17. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
Zabetian CP; Hutter CM; Factor SA; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Kay DM; Yearout D; Montimurro JS; Edwards KL; Samii A; Payami H
Ann Neurol; 2007 Aug; 62(2):137-44. PubMed ID: 17514749
[TBL] [Abstract][Full Text] [Related]
18. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
[TBL] [Abstract][Full Text] [Related]
19. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.
Winkler S; König IR; Lohmann-Hedrich K; Vieregge P; Kostic V; Klein C
Eur J Hum Genet; 2007 Nov; 15(11):1163-8. PubMed ID: 17637803
[TBL] [Abstract][Full Text] [Related]
20. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
